Track CBC results, bleeding or bruising, fatigue, infections, triggers, exposures, medicines, transfusions, and specialist follow-up.
Condition detail
Leukemia
Leukemia is a blood cancer condition tracked with diagnosis details, symptoms, labs, treatments, side effects, infection precautions, imaging, and oncology plans.

Connected records
Database matches for this condition

Cold hands and feet
Cold hands and feet is a heart, blood vessel, or circulation-related symptom that may be useful to track with pulse, blood pressure, swelling, exertion, and medication timing.

Dizziness
Dizziness is a heart, blood vessel, or circulation-related symptom that may be useful to track with pulse, blood pressure, swelling, exertion, and medication timing.

Palpitations
Palpitations is a heart, blood vessel, or circulation-related symptom that may be useful to track with pulse, blood pressure, swelling, exertion, and medication timing.

Fatigue
Fatigue is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General weakness
General weakness is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Medication side effects
Medication side effects is a possible medicine, injection, allergy, or exposure-related symptom that is useful to record with timing, dose, route, and product details.

Bone pain
Bone pain is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Falls
Falls is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Joint swelling
Joint swelling is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Muscle weakness
Muscle weakness is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.
Allopurinol
Used for: Allopurinol tablets are indicated for: The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) The management of adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels The management of adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in.
Azacitidine for
Used for: Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of: Adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Dasatinib
Used for: Dasatinib tablets are indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Decitabine
Used for: Decitabine for Injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
Doxorubicin hydrochloride
Used for: Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: • as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer ( 1.1 ) • for the treatment of: acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas.
Fludarabine phosphate
Used for: Fludarabine Phosphate Injection is a nucleotide metabolic inhibitor indicated for: The treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. Benefit in treatment-naïve or non-refractory CLL patients is not established.
Imatinib mesylate
Used for: Imatinib mesylate is a kinase inhibitor indicated for the treatment of: • Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase ( 1.1 ) • Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy ( 1.2 ) • Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphobl.
Methotrexate
Used for: Methotrexate tablets are a diydrofolate reductase inhibitor indicated for the: • Treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen (1.1) • Treatment of adults with mycosis fungoides (1.1) • Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen (1.1) • Treatment of adults with rheumatoid arthritis (1.2) • Treatment of pediatric patients with polyarticular juv.
Nelarabine
Used for: Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.
Tretinoin
Used for: Tretinoin capsules are indicated for the induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL) characterized by the presence of the t(15;17) translocation or PML/RARα gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.